Farmaceutica REMEDIA S.A. (BVB:RMAH)

Farmaceutica REMEDIA Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	6.96	7.2	5.81	7.23	37.77
Depreciation & Amortization	2.63	5.06	4.02	1.11	0.98
Other Amortization	-	-	-	0.09	0.1
Other Operating Activities	9.37	10.96	-11.81	-5.8	-52.37
Operating Cash Flow	18.96	23.22	-1.99	2.63	-13.52
Operating Cash Flow Growth	-18.34%	-	-	-	-
Capital Expenditures	-1.79	-1.38	-0.04	-0.04	-0.08
Sale of Property, Plant & Equipment	0.35	0.35	0.2	0.48	39.9
Other Investing Activities	2.06	0.07	0.08	0.14	0.07
Investing Cash Flow	0.62	-0.97	0.24	0.58	39.89
Short-Term Debt Issued	-	-	-	-	18.5
Total Debt Issued	-	-	-	-	18.5
Short-Term Debt Repaid	-	-	-	-	-18.82
Total Debt Repaid	-	-	-	-	-18.82
Net Debt Issued (Repaid)	-	-	-	-	-0.32
Repurchase of Common Stock	-	-1.5	-	-	-
Common Dividends Paid	-6.29	-4.19	-4.47	-13.35	-1.99
Other Financing Activities	-0.14	-0	-0.05	0.01	0.02
Financing Cash Flow	-6.43	-5.7	-4.52	-13.35	-2.29
Miscellaneous Cash Flow Adjustments	-0	-0.14	0.14	-	-0
Net Cash Flow	13.16	16.41	-6.13	-10.13	24.07
Free Cash Flow	17.17	21.84	-2.03	2.59	-13.6
Free Cash Flow Growth	-21.36%	-	-	-	-
Free Cash Flow Margin	2.31%	3.68%	-0.38%	0.54%	-3.08%
Free Cash Flow Per Share	0.18	0.23	-0.02	0.03	-0.13
Cash Interest Paid	-	-	0.07	-	0.1
Cash Income Tax Paid	5.31	1.61	1.29	1.55	5.01
Levered Free Cash Flow	19.84	21.82	1.54	10.32	-2.41
Unlevered Free Cash Flow	19.9	21.9	1.64	10.39	-2.31
Change in Net Working Capital	-11.16	-14	6.36	-4.05	5.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.